Subthalamic nucleus deep brain stimulation for Parkinson's disease: 8 years of follow-up

Translational Neurodegeneration

Volumn 2, Issue 1, 2013, Pages

  Li, Dianyou ^a   Cao, Chunyan ^a   Zhang, Jing ^a   Zhan, Shikun ^a   Chen, Shengdi ^a   Sun, Bomin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Deep brain stimulation; Long term effects; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SKIN INJURY; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84883603000     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-2-11     Document Type: Article

References (18)

1. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998, 339:1105-1111. 10.1056/NEJM199810153391603, 9770557.
2. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001, 56:548-551. 10.1212/WNL.56.4.548, 11222806.
3. Carvalho GA, Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 2001, 171:405-417. 10.1006/exnr.2001.7742, 11573992.
4. Lyons KE, Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg 2005, 103:252-255. 10.3171/jns.2005.103.2.0252, 16175854.
5. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934. 10.1056/NEJMoa035275, 14614167.
6. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999, 14:572-584. 10.1002/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C, 10435493.
7. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442. 10.1212/WNL.17.5.427, 6067254.
8. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001, 345:956-963. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.
9. Bomin S, Kangyong Liu LL, Li P, Dianyou L, Zhipei L, Daokuan L. Bilateral deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease. Chin J Neurosurg 2002, 18:8-11.
10. Fasano A, Romito LM, Daniele A, Piano C, Zinno M, Bentivoglio AR, Albanese A. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010, 133:2664-2676. 10.1093/brain/awq221, 20802207.
11. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J, Kulisevsky J, Obeso JA, Albanese A, Hariz MI. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010, 25:578-586. 10.1002/mds.22735, 20213817.
12. Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ. How do parkinsonian signs return after discontinuation of subthalamic DBS?. Neurology 2003, 60:78-81. 10.1212/WNL.60.1.78, 12525722.
13. Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007, 22:990-997. 10.1002/mds.21482, 17443692.
14. Moro E, Esselink RJ, Benabid AL, Pollak P. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation. Brain 2002, 125:2408-2417. 10.1093/brain/awf249, 12390968.
15. Castrioto A, Lozano AM, Poon YY, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011, 68:1550-1556. 10.1001/archneurol.2011.182, 21825213.
16. Goetz CG, Stebbins GT, Blasucci LM. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Mov Disord 2000, 15:479-484. 10.1002/1531-8257(200005)15:3<479::AID-MDS1009>3.0.CO;2-P, 10830412.
17. Moreau C, Defebvre L, Destee A, Bleuse S, Clement F, Blatt JL, Krystkowiak P, Devos D. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2008, 71:80-84. 10.1212/01.wnl.0000303972.16279.46, 18420482.
18. Brozova H, Barnaure I, Alterman RL, Tagliati M. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 2009, 72:770-771. 10.1212/01.wnl.0000339385.187472.7d, 19237711.